(Q38321988)

English

Functional characterization of structural alterations in the sequence of the vasodilatory peptide maxadilan yields a pituitary adenylate cyclase-activating peptide type 1 receptor-specific antagonist

scientific article

Statements

Functional characterization of structural alterations in the sequence of the vasodilatory peptide maxadilan yields a pituitary adenylate cyclase-activating peptide type 1 receptor-specific antagonist (English)
1 August 1999
23103-23110

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit